摘要
Sir, In November 2015 a new plasmid-mediated mechanism of resistance to colistin, MCR-1, was reported in Escherichia coli collected in 2013 from a pig in China; this finding attracted great concern worldwide.1 The mcr-1 gene was associated with the ISApl1 mobile element and was located on an IncI2-type plasmid. In the same study, 244 other mcr-1-positive E. coli isolates from pigs and retail meat, and 16 inpatient E. coli or Klebsiella pneumoniae isolates were confirmed. Soon other groups reported on mcr-1, mainly in E. coli and less so in other Enterobacteriaceae from livestock, meat, humans, river water or vegetables from Asia and Europe, and sporadically other continents.2,3 The ‘oldest’ MCR-1 livestock organisms found so far in Asia and Europe date back to the 1980s and 2005, respectively, indicating their long-lasting unnoticed occurrence.3,4 Only a few reports commented on the molecular characteristics of mcr-1-positive E. coli isolates; however, their remarkable clonal diversity was documented.5mcr-1 resides on plasmids varying in size and replicons, usually with ISApl1 upstream.1,3 Various β-lactamases are observed in MCR-1 producers, including ESBLs, AmpC cephalosporinases and carbapenemases,2,3 revealing alarming resistance accumulation. Here, to the best of our knowledge, we report the first identification of an MCR-1-producing organism in Poland. On 3 October 2015, a female patient in her late 50s with pneumonia, diarrhoea and urinary tract infection was admitted to a hospital in southern Poland. Colistin-resistant E. coli was isolated from urine on the second day, indicating a community-onset infection. The patient had no travel history, but, living in the countryside, might have had contact with livestock. The E. coli isolate 3898/15 was sent to the National Reference Centre for Susceptibility Testing (NRCST) for surveillance and confirmation purposes. MLST, carried out as described previously,6 classified the isolate as ST617, a member of the clonal complex ST10 cplx (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). Antimicrobial susceptibility was tested with MIC Test Strips (Liofilchem, Roseto degli Abruzzi, Italy) and interpreted according to EUCAST.7 Colistin resistance was confirmed, with an MIC of 3 mg/L. The isolate was also resistant to penicillins, amoxicillin/clavulanate, cephalosporins (except cefepime), aztreonam, fluoroquinolones, tetracycline and co-trimoxazole, though susceptible to piperacillin/tazobactam, carbapenems, aminoglycosides and tigecycline (Table 1). Antimicrobial susceptibility of the MCR-1-producing E. coli ST617 isolate Antimicrobial susceptibility of the MCR-1-producing E. coli ST617 isolate The mcr-1 gene was detected by PCR as reported previously.1 Its genetic context was assessed by PCR mapping and sequencing, with consecutive primers based on the sequence of the mcr-1 plasmid pHNSHP45 from China (Table S1, available as Supplementary data at JAC Online).1 The ISApl1–mcr-1 region was identical to that in pHNSHP45.1 The entire ISApl1 tnpA gene was present upstream of mcr-1, and so was the downstream fragment of ∼730 bp (mapped by the primer mcr-1-down-R). The further downstream pHNSHP45 gene ydfA was not identified. The plasmid analysis comprised PCR-based replicon typing (PBRT)8 and nuclease S1 (TaKaRa, Shiga, Japan) plasmid profiling,9 followed by hybridization with replicon and mcr-1 probes using the Amersham ECL Direct Nucleic Acid Labelling System (GE Healthcare, Little Chalfont, UK). Five plasmids of <50, ∼90, ∼160, ∼210 and ∼250 kb were identified, with the ∼250 kb plasmid carrying mcr-1. Replicons IncX1, IncA/C2 and IncFIB were detected and assigned to plasmids of <50, ∼160 and ∼210 kb, respectively. Additionally, PBRT yielded the IncB/O-specific amplicon, but hybridization with this probe failed repeatedly. The transfer of the mcr-1 plasmid by mating and electroporation was performed with colistin at concentrations of 0.5, 1 and 2 mg/L as a selective agent. All these experiments were not successful despite several attempts. The phenotypic detection of ESBL and/or AmpC was done using the ESBL double-disc synergy test in the absence and presence of 250 mg/L cloxacillin, indicating high-level AmpC expression only, followed by PCR and sequencing of the blaCMY-2 gene. blaCMY-2 hybridized with the ∼160 kb IncA/C2 plasmid. In mid-2014, the NRCST commenced a routine surveillance of resistance to colistin in Poland. Of 37 resistant Enterobacteriaceae isolates sent by microbiology laboratories by the end of 2015, E. coli 3898/15 was the only MCR-1 producer. Even though fragmentary, the patient's data correspond to the hypothesis that an agriculture-associated MCR-1 reservoir exists.1–4 In Europe MCR-1-positive patients have to date been identified only in Denmark, Germany, Italy, Sweden, Switzerland, the Netherlands and the UK2,5; however, MCR-1 organisms in livestock are now known to have been present in the continent for over 10 years.3 The MCR-1-producing E. coli isolates studied so far have been classified into 18 STs, 12 of which had been observed in both animals and humans (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). This also includes the ST617 found in this study, observed worldwide in various animals, humans and the environment. Its mcr-1 gene was present in the apparently stable genetic context and was carried by a large, probably non-typeable and non-self-transmissible plasmid. The isolate characteristics accord with the growing knowledge on E. coli as the major MCR-1 host and the high genetic diversity of MCR-1-positive isolates. This work was supported by the grant SPUB MIKROBANK from the Polish Ministry of Science and Higher Education. None to declare.